Report of the 2022 Banff Heart Concurrent : Focus on non-human leukocyte antigen antibodies in rejection and the pathology of "mixed" rejection
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved..
The Banff Heart Concurrent Session, held as part of the 16th Banff Foundation for Allograft Pathology Conference at Banff, Alberta, Canada, on September 21, 2022, focused on 2 major topics: non-human leukocyte antigen (HLA) antibodies and mixed rejection. Each topic was addressed in a multidisciplinary fashion with clinical, immunological, and pathology perspectives and future developments and prospectives. Following the Banff organization model and principles, the collective aim of the speakers on each topic was to • Determine current knowledge gaps in heart transplant pathology • Identify limitations of current pathology classification systems • Discuss next steps in addressing gaps and refining classification system.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 24(2024), 4 vom: 29. Apr., Seite 533-541 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fedrigo, Marny [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Heart transplantation |
|---|
| Anmerkungen: |
Date Completed 02.04.2024 Date Revised 02.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ajt.2023.10.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363311750 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363311750 | ||
| 003 | DE-627 | ||
| 005 | 20240402235824.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajt.2023.10.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1361.xml |
| 035 | |a (DE-627)NLM363311750 | ||
| 035 | |a (NLM)37838218 | ||
| 035 | |a (PII)S1600-6135(23)00794-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fedrigo, Marny |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Report of the 2022 Banff Heart Concurrent |b Focus on non-human leukocyte antigen antibodies in rejection and the pathology of "mixed" rejection |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.04.2024 | ||
| 500 | |a Date Revised 02.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a The Banff Heart Concurrent Session, held as part of the 16th Banff Foundation for Allograft Pathology Conference at Banff, Alberta, Canada, on September 21, 2022, focused on 2 major topics: non-human leukocyte antigen (HLA) antibodies and mixed rejection. Each topic was addressed in a multidisciplinary fashion with clinical, immunological, and pathology perspectives and future developments and prospectives. Following the Banff organization model and principles, the collective aim of the speakers on each topic was to • Determine current knowledge gaps in heart transplant pathology • Identify limitations of current pathology classification systems • Discuss next steps in addressing gaps and refining classification system | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a heart transplantation | |
| 650 | 4 | |a mixed rejection | |
| 650 | 4 | |a non-HLA antibodies | |
| 650 | 4 | |a pathology | |
| 700 | 1 | |a Berry, Gerald J |e verfasserin |4 aut | |
| 700 | 1 | |a Coutance, Guillaume |e verfasserin |4 aut | |
| 700 | 1 | |a Reed, Elaine F |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Chieh-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Giarraputo, Alessia |e verfasserin |4 aut | |
| 700 | 1 | |a Kransdorf, Evan |e verfasserin |4 aut | |
| 700 | 1 | |a Thaunat, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Goddard, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Angelini, Annalisa |e verfasserin |4 aut | |
| 700 | 1 | |a Neil, Desley A H |e verfasserin |4 aut | |
| 700 | 1 | |a Bruneval, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Duong Van Huyen, Jean-Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Loupy, Alexandre |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Dylan V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons |d 2001 |g 24(2024), 4 vom: 29. Apr., Seite 533-541 |w (DE-627)NLM119667924 |x 1600-6143 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2024 |g number:4 |g day:29 |g month:04 |g pages:533-541 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajt.2023.10.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2024 |e 4 |b 29 |c 04 |h 533-541 | ||